The new chief executive of the Complementary Healthcare Council of Australia has used his maiden speech to call on the incoming government to invest making the country healthier.
As a new head of operations works out how best to guide GlaxoSmithKline’s China operation through a bribery scandal that has hit the world's headlines, industry watchers have have said the company is just the tip of the iceberg in a pharmaceutical...
SoHo Flordis International, an Australian/Indonesian natural medicines company, has acquired two companies in the space, ProThera, based in Reno, NV and Swiss company Ginsana.
By Dr Wendy Morrow, executive director, Complementary Healthcare Council of Australia
Something is not right when regulators increasingly opt to assess complementary medicines against medical criteria—in much the same way as pharmaceutical drugs are assessed.
Australia’s leading complementary healthcare association has slammed the government for snubbing it while appointing the new Therapeutic Goods Advisory Council (TGAC).
The world’s biggest food player, Nestlé, is investing A$17m (€13.6m) to renovate an Australian facility so it can produce medical foods for its Health Science division.
BioGaia has signed an agreement with Ferozsons Laboratories for the exclusive rights to sell probiotic drops and tablets in Pakistan. The products will be sold under the BioGaia brand and launch is planned for 2013.
Biothera has named Ryusendoas its exclusive distributor in Japan of Wellmune WGP and its other immune health ingredients for foods, beverages, and supplements.
The Australian medicines regulator is warning people off a weight management herbal called St Nirvana, after product testing revealed illegal doses of the banned pharma ingredient, sibutramine.
The ongoing rethinking of the rules governing herbal products in Australia has highlighted more than 30 herbs for safety review, according to the Therapeutic Goods Administration (TGA).
